An L-amino acid producing bacterium of the Enterobacteriaceae family is described, wherein the bacterium has been modified so as to not produce type I fimbrial adhesin protein is cultured in a medium to produce and excrete said L-amino acid in the medium, and collecting said L-amino acid from the medium.
Drawings
Claims2
A method for producing an L-amino acid, comprising
cultivating an Escherichia coli in a medium, and
collecting said L-amino acid from the medium,
wherein the fimH gene of said Escherichia coli has been inactivated by a method selected from the group consisting of
A) deleting the fimH gene,
B) modifying a promoter or a Shine-Dalgarno sequence of-the fimH gene,
C) introducing a missense mutation into the fimH gene,
D) introducing a nonsense mutation into the fimH gene, and
E) introducing a frame shift mutation into the fimH gene and wherein said fimH gene is selected from the group consisting of:
(a) a DNA comprising the nucleotide sequence of SEQ ID NO:1, and
(b) a DNA that is able to hybridize with the complementary strand of the nucleotide of SEQ ID NO:1 under conditions comprising washing at 60° C. and at a salt concentration corresponding to 1×SSC, 0.1 ×SDS, and wherein the DNA encodes fimH.
11/275,562Filed 17 Jan 2006 · us provisional application
Priority
JP 2005-00982618 Jan 2005
Published
US 2006/0160191 A120 Jul 2006
Granted
16 Jun 2009
Term ends
22 Jan 2027Estimated · howhide20 years from earliest known nonprovisional domestic filing plus recorded patent term adjustment, including 370 days of adjustment. Maintenance-fee lapses, terminal disclaimers and statutory extensions have not been checked. The continuity chain may be incomplete; this is not an enforceability determination.
#The present invention relates to the fermentation microbiological industry, and specifically to a method for producing an L-amino acid using a bacterium of the Enterobacteriaceae family, wherein the bacterium has been modified so as to not produce type I fimbrial adhesin protein. L-amino acids are employed as components of pharmaceuticals, animal feed additives, seasonings, and various other nutritive mixtures.
#The bacterium of the present invention is a bacterium having the ability to produce an L-amino acid and which belongs to the Enterobacteriaceae family. The bacterium of the present invention has been modified so as to not produce type I fimbrial adhesin protein. The ability to produce L-amino acids may include production of any single L-amino acid, or production of multiple L-amino acids. Examples of produced L-amino acids of the present invention include L-lysine, L-glutamic acid, L-threonine, L-valine, L-leucine, L-isoleucine, L-serine, L-aspartic acid, L-asparagine, L-glutamine, L-arginine, L-cysteine (cystine), L-methionine, L-phenylalanine, L-tryptophan, L-tyrosine, L-glycine, L-alanine, L-proline, L-ornithine, L-citrulline, and L-homoserine. L-lysine, L-threonine, and L-glutamic acid are particularly desirable.
#The phrase “ability to produce an L-amino acid” refers to the ability of a bacterium of the Enterobacteriaceae family to produce and cause accumulation of an L-amino acid in the bacterial cells or into a medium to a degree which permits its recovery from the bacterial cells or the medium when the bacterium is cultured in the medium. The bacterium which has this ability may originally have had the ability to produce an L-amino acid, or may be a bacterium, such as those set forth below, that has been modified by a mutation method or recombinant DNA technique to impart the ability to produce an L-amino acid. The bacterium of the present invention may also be one that has had the ability to produce an L-amino acid imparted to it by a modification which results in prevention of production of type I fimbrial adhesin production.